Peter Black, MD, FACS, FRCSC, Author at Grand Rounds in Urology

Peter Black, MD, FACS, FRCSC

University of British Columbia

Vancouver, British Columbia, Canada

Dr. Peter Black is a urologic oncologist at Vancouver General Hospital, a research scientist at the Vancouver Prostate Centre, and a Professor in the Department of Urologic Sciences at the University of British Columbia (UBC). He received his undergraduate degree from UBC and his medical degree from Johannes Gutenberg University in Mainz, Germany. He completed his urologic training at the University of Washington in Seattle and a Fellowship in Urologic Oncology at MD Anderson Cancer Center in Houston, Texas. He has a clinical subspecialty interest in bladder cancer. He maintains a grant-funded translational research program in urothelial carcinoma and is an active cancer clinical trialist in this field.

Disclosures:

Talks by Peter Black, MD, FACS, FRCSC

Perioperative Pathways: What We Know Works

Posted by Peter Black, MD, FACS, FRCSC | Mar 2018

Peter Black, MD, FRCSC, provides an overview of the current Enhanced Recovery After Surgery (ERAS) protocol in the setting of radical cystectomy, recommendations from the ERAS Society, and how the practice increases bladder cancer patients’ quality of life. He also touches upon the possibility of adding alvimopan to ERAS protocol in the near future.

Urine Markers for Bladder Cancer

Posted by Peter Black, MD, FACS, FRCSC | Feb 2018

Peter Black, MD, FRCSC, discusses the benefits and limitations of the currently FDA approved urinary biomarkers for bladder cancer. He defines criteria for the ideal biomarker, which would reduce the need for other diagnostic tests, have a high sensitivity and specificity rate, and be cost-effective for patients, as well as the possibility of using biomarkers in place of cystoscopy.